Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- has_structure
- 1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
- evidence_priority
- DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
- has_known_aptamer
- 1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
- surface_class
- PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.
238 rows where has_cryoEM = 0, in_cev_map = 0 and surface_class = "A_assoc" sorted by evidence_priority descending
This data as json, CSV (advanced)
Suggested facets: aptamer_count_pubmed
surface_class 1
- A_assoc · 238 ✖
in_cev_map 1
- - · 238 ✖
has_cryoEM 1
- - · 238 ✖
has_activation_state_pdb_pair 1
- 0 238
| id | gene_symbol | protein_name | tier | evidence_priority ▲ | has_structure | surface_class | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P15884 | TCF4 | Transcription factor 4 | Tier 1 | 0.705 | 1 | A_assoc | 5 | 51.12 | 0 | 0 | 1 | 4 | 36252203, 17909039, 41851110, 37805109 | 0 | Pitt-Hopkins syndrome | 0.8490531860867685 | ||
| Q9NZK5 | ADA2 | Adenosine deaminase 2 | Tier 1 | 0.699 | 1 | A_assoc | 2 | 95.81 | 0 | 0 | 0 | 0 | 0 | deficiency of adenosine deaminase 2 | 0.8291292532404531 | |||
| Q99972 | MYOC | Myocilin | Tier 1 | 0.699 | 1 | A_assoc | 24 | 78.94 | 0 | 0 | 0 | 0 | 0 | glaucoma 1, open angle, A | 0.8294483747483756 | |||
| Q9UBH0 | IL36RN | Interleukin-36 receptor antagonist protein | Tier 1 | 0.695 | 1 | A_assoc | 3 | 92.44 | 0 | 0 | 0 | 0 | 0 | psoriasis 14, pustular | 0.8155144873787125 | |||
| P20062 | TCN2 | Transcobalamin-2 | Tier 1 | 0.694 | 1 | A_assoc | 11 | 91.5 | 0 | 0 | 1 | 3 | 41935727, 39493449 | 0 | transcobalamin II deficiency | 0.8116989428679681 | ||
| Q96MK3 | FAM20A | Pseudokinase FAM20A | Tier 1 | 0.693 | 1 | A_assoc | 4 | 85.25 | 0 | 0 | 0 | 0 | 0 | amelogenesis imperfecta type 1G | 0.8106031517056754 | |||
| P55000 | SLURP1 | Secreted Ly-6/uPAR-related protein 1 | Tier 1 | 0.692 | 1 | A_assoc | 2 | 84.19 | 0 | 0 | 0 | 0 | 0 | mal de Meleda | 0.8064330379723671 | |||
| P45452 | MMP13 | Collagenase 3 | Tier 1 | 0.691 | 1 | A_assoc | 49 | 88.62 | 0 | 0 | 1 | 4 | 41754778, 40893365, 38471488, 38750696 | 0 | spondyloepimetaphyseal dysplasia, Missouri type | 0.8032079813035149 | ||
| Q13253 | NOG | Noggin | Tier 1.5 | 0.685 | 1 | A_assoc | 2 | 86.06 | 0 | 0 | 1 | 2 | 38397086 | 0 | proximal symphalangism 1A | 0.7844136456463046 | ||
| Q96S42 | NODAL | Nodal homolog | Tier 1 | 0.684 | 1 | A_assoc | 1 | 75.44 | 0 | 0 | 1 | 3 | 38155321, 24146916, 23918801 | 0 | heterotaxy, visceral, 5, autosomal | 0.7788051667024423 | ||
| P01138 | NGF | Beta-nerve growth factor | Tier 1.5 | 0.684 | 1 | A_assoc | 8 | 73.25 | 0 | 0 | 1 | 6 | 42015870, 38780008, 32982626, 21216401, 7545283, 29754498 | 0 | hereditary sensory and autonomic neuropathy type 5 | 0.7785402119369383 | ||
| P18510 | IL1RN | Interleukin-1 receptor antagonist protein | Tier 1.5 | 0.682 | 1 | A_assoc | 5 | 87.06 | 0 | 0 | 1 | 1 | 38928037 | 0 | sterile multifocal osteomyelitis with periostitis and pustulosis | 0.7734282711738736 | ||
| P29120 | PCSK1 | Neuroendocrine convertase 1 | Tier 1.5 | 0.682 | 1 | A_assoc | 3 | 82.5 | 0 | 0 | 0 | 0 | 0 | obesity due to prohormone convertase I deficiency | 0.773875795833803 | |||
| P00797 | REN | Renin | Tier 1 | 0.68 | 1 | A_assoc | 91 | 85.44 | 0 | 0 | 1 | 456 | 42025056, 42000159, 41992303, 41979049, 41942404, 41934998, 41909751, 41904852, 41851110, 41849890, 41794534, 41780402, 41770936, 41718462, 41711853, 41698160, 41671930, 41659919, 41629318, 41545413, 41538945, 41529264, 41519163, 41454539, 41443106, 41386094, 41330678, 41327249, 41249026, 41234744, 41207040, 41205456, 41175848, 41172349, 41171135, 41164194, 41161441, 41148632, 41118515, 41089000, 41067030, 41024479, 41002305, 40994449, 40968863, 40963922, 40893365, 40891676, 40870790, 40801503, 41906877, 40832436, 39923730, 39263947, 39129649, 38811951, 36190914, 35983901, 35907639, 35187107, 34619249, 34248841, 32981365, 32838280, 32527800, 31988066, 26746799, 21147843 | 0 | familial juvenile hyperuricemic nephropathy type 2 | 0.7657976389758877 | ||
| P20849 | COL9A1 | Collagen alpha-1(IX) chain | Tier 1 | 0.678 | 1 | A_assoc | 5 | 61.5 | 0 | 0 | 0 | 0 | 0 | Stickler syndrome | 0.7594904923903256 | |||
| P16112 | ACAN | Aggrecan core protein | Tier 1.5 | 0.677 | 1 | A_assoc | 4 | 51.91 | 0 | 0 | 0 | 0 | 0 | Familial osteochondritis dissecans | 0.7558487616449627 | |||
| P55789 | GFER | FAD-linked sulfhydryl oxidase ALR | Tier 1.5 | 0.677 | 1 | A_assoc | 7 | 76.88 | 0 | 0 | 0 | 0 | 0 | congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome | 0.7556346526616893 | |||
| Q12794 | HYAL1 | Hyaluronidase-1 | Tier 1.5 | 0.672 | 1 | A_assoc | 1 | 94.0 | 0 | 0 | 0 | 0 | 0 | Hyaluronidase deficiency | 0.7412407206736383 | |||
| Q92752 | TNR | Tenascin-R | Tier 1.5 | 0.672 | 1 | A_assoc | 2 | 78.5 | 0 | 0 | 0 | 0 | 0 | neurodevelopmental disorder, nonprogressive, with spasticity and transient opisthotonus | 0.7403484347367364 | |||
| O15520 | FGF10 | Fibroblast growth factor 10 | Tier 1.5 | 0.67 | 1 | A_assoc | 2 | 80.0 | 0 | 0 | 1 | 1 | 35415885 | 0 | Lacrimoauriculodentodigital syndrome | 0.7344198619465704 | ||
| Q9BQB4 | SOST | Sclerostin | Tier 1 | 0.666 | 1 | A_assoc | 3 | 70.81 | 0 | 0 | 1 | 32 | 42031715, 41736700, 41545413, 41276911, 41242313, 40464222, 40429697, 34361085, 33717084, 33334063, 21204783, 42030934, 41450662, 41226313, 39470582, 39007037, 38444701, 38074899, 37481136, 35966595, 35869074, 35646527 | 0 | sclerosteosis 1 | 0.7184345506579789 | ||
| O00300 | TNFRSF11B | Tumor necrosis factor receptor superfamily member 11B | Tier 1.5 | 0.666 | 1 | A_assoc | 1 | 86.5 | 0 | 0 | 1 | 1 | 15562003 | 0 | juvenile Paget disease | 0.7184894548525037 | ||
| Q99574 | SERPINI1 | Neuroserpin | Tier 1 | 0.665 | 1 | A_assoc | 3 | 88.12 | 0 | 0 | 0 | 0 | 0 | familial encephalopathy with neuroserpin inclusion bodies | 0.7162803151916303 | |||
| P11686 | SFTPC | Surfactant protein C | Tier 1.5 | 0.663 | 1 | A_assoc | 3 | 70.06 | 0 | 0 | 0 | 0 | 0 | Congenital pulmonary alveolar proteinosis | 0.7110128683619542 | |||
| O43897 | TLL1 | Tier 1.5 | 0.662 | 1 | A_assoc | 1 | 80.31 | 0 | 0 | 0 | 0 | 0 | atrial heart septal defect | 0.7050140477090344 | ||||
| P19835 | CEL | Bile salt-activated lipase | Tier 1.5 | 0.658 | 1 | A_assoc | 7 | 82.56 | 0 | 0 | 1 | 2 | 39653009, 34940276 | 0 | MODY | 0.6940743944678538 | ||
| O43323 | DHH | Desert hedgehog protein | Tier 1 | 0.657 | 1 | A_assoc | 5 | 84.38 | 0 | 0 | 1 | 1 | 18698484 | 0 | 46,XY gonadal dysgenesis-motor and sensory neuropathy syndrome | 0.6912706692651148 | ||
| P27352 | CBLIF | Cobalamin binding intrinsic factor | Tier 1.5 | 0.655 | 1 | A_assoc | 2 | 90.5 | 0 | 0 | 0 | 0 | 0 | hereditary intrinsic factor deficiency | 0.683930100359911 | |||
| Q9Y5C1 | ANGPTL3 | Angiopoietin-related protein 3 | Tier 1.5 | 0.652 | 1 | A_assoc | 1 | 79.62 | 0 | 0 | 1 | 1 | 23770039 | 0 | familial hypobetalipoproteinemia 2 | 0.6739043862507132 | ||
| Q9Y5K2 | KLK4 | Kallikrein-4 | Tier 1 | 0.65 | 1 | A_assoc | 18 | 90.12 | 0 | 0 | 1 | 2 | 30114962, 35323639 | 0 | Hypomaturation amelogenesis imperfecta | 0.6659029046455642 | ||
| O95390 | GDF11 | Growth/differentiation factor 11 | Tier 1 | 0.636 | 1 | A_assoc | 5 | 73.12 | 0 | 0 | 1 | 7 | 40664633, 39909827, 31638376, 23663781, 32408813 | 0 | vertebral hypersegmentation and orofacial anomalies | 0.6207007733160915 | ||
| P05230 | FGF1 | Fibroblast growth factor 1 | Tier 1 | 0.633 | 1 | A_assoc | 96 | 90.69 | 0 | 0 | 1 | 3 | 35415885, 33536494, 27663888 | 0 | cancer | 0.6088477966360052 | ||
| P22894 | MMP8 | Neutrophil collagenase | Tier 1 | 0.631 | 1 | A_assoc | 25 | 90.38 | 0 | 0 | 1 | 4 | 35821507, 34183667, 33534888, 30197987 | 0 | acne | 0.603247809982021 | ||
| P09237 | MMP7 | Matrilysin | Tier 1 | 0.631 | 1 | A_assoc | 16 | 87.81 | 0 | 0 | 1 | 9 | 41890985, 37022120, 36508319, 33742062, 31844116, 30553167, 28738067, 27836219 | 0 | acne | 0.603247809982021 | ||
| O76093 | FGF18 | Fibroblast growth factor 18 | Tier 1.5 | 0.631 | 1 | A_assoc | 1 | 87.56 | 0 | 0 | 1 | 1 | 35415885 | 0 | cancer | 0.6028027301556572 | ||
| P08620 | FGF4 | Fibroblast growth factor 4 | Tier 1.5 | 0.631 | 1 | A_assoc | 1 | 81.5 | 0 | 0 | 1 | 3 | 35415885, 33536494, 7547864 | 0 | cancer | 0.6026669167438079 | ||
| Q15818 | NPTX1 | Neuronal pentraxin-1 | Tier 1.5 | 0.628 | 1 | A_assoc | 1 | 75.75 | 0 | 0 | 0 | 0 | 0 | spinocerebellar ataxia 50 | 0.5937598292127286 | |||
| P07098 | LIPF | Gastric triacylglycerol lipase | Tier 1.5 | 0.626 | 1 | A_assoc | 1 | 89.75 | 0 | 0 | 0 | 0 | 0 | obesity | 0.5864662753480862 | |||
| P35247 | SFTPD | Pulmonary surfactant-associated protein D | Tier 1 | 0.624 | 1 | A_assoc | 31 | 65.5 | 0 | 0 | 1 | 1 | 39884764 | 0 | COVID-19 | 0.5808114412785164 | ||
| Q9GZX6 | IL22 | Interleukin-22 | Tier 1.5 | 0.619 | 1 | A_assoc | 6 | 88.12 | 0 | 0 | 1 | 7 | 34208021, 33869115, 28942363, 26792955, 37041650 | 0 | atopic eczema | 0.5627493881195745 | ||
| O95150 | TNFSF15 | Tumor necrosis factor ligand superfamily member 15 | Tier 1 | 0.618 | 1 | A_assoc | 7 | 81.06 | 0 | 0 | 1 | 2 | 35026285 | 0 | leprosy | 0.5605330843692238 | ||
| Q9UNA0 | ADAMTS5 | A disintegrin and metalloproteinase with thrombospondin motifs 5 | Tier 1 | 0.613 | 1 | A_assoc | 7 | 77.56 | 0 | 0 | 1 | 3 | 35700850, 26594036 | 0 | Abnormality of the skeletal system | 0.5442996355354548 | ||
| Q9HCB6 | SPON1 | Spondin-1 | Tier 1 | 0.613 | 1 | A_assoc | 4 | 77.25 | 0 | 0 | 1 | 2 | 31640794, 27640094 | 0 | atrial fibrillation | 0.5420224587351377 | ||
| Q8IU60 | DCP2 | m7GpppN-mRNA hydrolase | Tier 1 | 0.613 | 1 | A_assoc | 33 | 66.81 | 0 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.5442061583114092 | |||
| O00175 | CCL24 | C-C motif chemokine 24 | Tier 1.5 | 0.613 | 1 | A_assoc | 2 | 82.12 | 0 | 0 | 0 | 0 | 0 | Iron deficiency anemia | 0.5428194908352497 | |||
| Q4VCS5 | AMOT | Angiomotin | Tier 1 | 0.608 | 1 | A_assoc | 18 | 56.75 | 0 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.5261379875719714 | |||
| P56703 | WNT3 | Proto-oncogene Wnt-3 | Tier 1.5 | 0.608 | 1 | A_assoc | 1 | 88.25 | 0 | 0 | 1 | 2 | 40168709, 18673242 | 0 | neurodegenerative disease | 0.5272184953415704 | ||
| O14793 | MSTN | Growth/differentiation factor 8 | Tier 1 | 0.602 | 1 | A_assoc | 5 | 78.75 | 0 | 0 | 1 | 4 | 41020397, 40664633, 40313273, 33334063 | 0 | myostatin-related muscle hypertrophy | 0.5055829543398623 | ||
| Q6IQ23 | PLEKHA7 | Pleckstrin homology domain-containing family A member 7 | Tier 1 | 0.599 | 1 | A_assoc | 3 | 56.69 | 0 | 0 | 0 | 0 | 0 | open-angle glaucoma | 0.49623877592982996 | |||
| O15496 | PLA2G10 | Group 10 secretory phospholipase A2 | Tier 1 | 0.597 | 1 | A_assoc | 7 | 88.0 | 0 | 0 | 1 | 1 | 9526554 | 0 | neurodegenerative disease | 0.48857112988743956 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
-- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
-- Transparent weights over harvested evidence: structure 0.35, disease importance
-- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
-- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
-- are predictions/detections, NOT measured EV-surface exposure.
ROUND(
0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
+ 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
+ 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
+ 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
, 3) AS evidence_priority,
(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
sc.surface_class,
f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;